Pharvaris Bv Stock Number Of Shares Shorted
| PHVS Stock | USD 25.39 0.56 2.26% |
Fundamental analysis of Pharvaris allows traders to better anticipate movements in Pharvaris' stock price by examining its financial health and performance throughout various phases of its business cycle.
Pharvaris | Build AI portfolio with Pharvaris Stock |
Pharvaris BV Company Number Of Shares Shorted Analysis
Pharvaris' Number of Shares Shorted is the total amount of shares that are currently sold short by investors. When a stock is sold short, the short seller assumes the responsibility of repurchasing the stock at a lower price. The speculator will make money if the stock goes down in price or will experience a loss if the stock price goes up.
More About Number Of Shares Shorted | All Equity Analysis
Shares Shorted | = | Shorted by Public | + | by Institutions |
Current Pharvaris Number Of Shares Shorted | 531.88 K |
Most of Pharvaris' fundamental indicators, such as Number Of Shares Shorted, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pharvaris BV is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
If a large number of investors decide to short sell an equity instrument within a small period of time, their combined action can significantly affect the price of the stock.
| Competition |
Based on the recorded statements, Pharvaris BV has 531.88 K of outstending shares currently sold short by investors. This is 83.38% lower than that of the Biotechnology sector and 89.57% lower than that of the Health Care industry. The number of shares shorted for all United States stocks is 88.7% higher than that of the company.
Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Pharvaris Fundamentals
| Return On Equity | -0.54 | |||
| Return On Asset | -0.32 | |||
| Current Valuation | 1.23 B | |||
| Shares Outstanding | 64.96 M | |||
| Shares Owned By Insiders | 5.31 % | |||
| Shares Owned By Institutions | 96.04 % | |||
| Number Of Shares Shorted | 531.88 K | |||
| Price To Book | 4.46 X | |||
| EBITDA | (145.59 M) | |||
| Net Income | (132.4 M) | |||
| Cash And Equivalents | 201.38 M | |||
| Cash Per Share | 5.96 X | |||
| Total Debt | 861.47 K | |||
| Debt To Equity | 0 % | |||
| Current Ratio | 12.85 X | |||
| Book Value Per Share | 4.81 X | |||
| Cash Flow From Operations | (120.13 M) | |||
| Short Ratio | 2.30 X | |||
| Earnings Per Share | (3.35) X | |||
| Price To Earnings To Growth | (0.12) X | |||
| Target Price | 37.5 | |||
| Number Of Employees | 118 | |||
| Beta | -2.78 | |||
| Market Capitalization | 1.61 B | |||
| Total Asset | 291.37 M | |||
| Retained Earnings | (402.26 M) | |||
| Working Capital | 266.44 M | |||
| Net Asset | 291.37 M |
About Pharvaris Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pharvaris BV's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pharvaris using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pharvaris BV based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Pharvaris Stock Analysis
When running Pharvaris' price analysis, check to measure Pharvaris' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pharvaris is operating at the current time. Most of Pharvaris' value examination focuses on studying past and present price action to predict the probability of Pharvaris' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pharvaris' price. Additionally, you may evaluate how the addition of Pharvaris to your portfolios can decrease your overall portfolio volatility.